Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is NBIX A Good Stock To Buy?’

Howard Marks OAKTREE CAPITAL MANAGEMENT

Hedge Funds Are Dumping Neurocrine Biosciences, Inc. (NBIX)

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating......(read more)
Kris Jenner - Rock Springs Capital

Did Hedge Funds Drop The Ball On Neurocrine Biosciences, Inc. (NBIX) ?

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due......(read more)
CITADEL INVESTMENT GROUP

Should You Buy Neurocrine Biosciences, Inc. (NBIX)?

During the first half of the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by about 4 percentage points as investors......(read more)
biotech, molecular, soil, scientist, closeup, experiment, goggles, workwear, biologist, protective, researching, green, sprout, molecules, formula, eco, future, sample,

Is Neurocrine Biosciences, Inc. (NBIX) a Good Stock to Buy?

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed

Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......(read more)
Syda Productions/Shutterstock.com

Hedge Funds Growing Fond Of Neurocrine Biosciences, Inc. (NBIX)

Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive......(read more)